High expression of the ephrin type-A receptor 4 (EPHA4) gene in glioma cells was found to potentiate FGF2–FGFR1 signaling and promote cell growth and migration through the AKT/MAPK and RAC1/CDC42 pathways, respectively [50]. This evidence concerns the gene EPHA4 and central nervous system cancer.